Comparison of three ELISA tests for seroepidemiology of bovine fascioliosis.
The aim of the present study was to compare the sensitivity, specificity and usefulness of the DIG-ELISA, DOT-ELISA and Indirect ELISA tests for determining the seroprevalence of fasciolosis in cattle under tropical conditions in Mexico. To standardize the tests, positive and negative sera to F. hepatica from 88 Holstein Freisian adult cows located in an enzootic area of fascioliosis and 88 crossbred adult cattle from a fluke-free area were used. For the epidemiological study, 85 crossbred cattle between 1 to 7 years of age were used. Animals were bled every two months, from March 1995 to September 1996 and the sera obtained were stored at -70 degrees C, until used. Indirect ELISA showed a sensitivity of 96.5% and a specificity of 98.8%, DIG-ELISA 97.5% and 80.0% and DOT-ELISA 93.1% and 95.4%, respectively. During 1995, Indirect ELISA yielded the highest levels of IgG anti-F. hepatica antibodies. However, in 1996, after animal treatment with triclabendazole, DIG-ELISA tended to show higher percentages of antibody-positive animals, but it was not significantly different (p>0.05) from the other tests. Comparisons made in parallel to the faecal sedimentation test demonstrated that all serological tests detected higher percentages of positive animals. Only one serum out of ten (10%) of Paramphistomum spp. cross-reacted with the DOT-ELISA test, but no cross-reaction was observed with sera from animals with other parasites. All ELISA tests were highly sensitive and specific; they may be recommended for use in seroepidemiological surveys for F. hepatica.
Proyecto Fasciolosis, CENID-Parasitología/INIFAP/SAGAR, Carretera Cuernavaca-Cuautla, Morelos, Mexico.
F
F
Ibarra
N
N
Montenegro
Y
Y
Vera
C
C
Boulard
H
H
Quiroz
J
J
Flores
P
P
Ochoa
D000818:Animals; D000871:Anthelmintics / Q000494:pharmacology / Q000627:therapeutic use; D000909:Antibodies, Helminth / Q000097:blood*; D000947:Antigens, Helminth / Q000096:biosynthesis / Q000737:chemistry; D001562:Benzimidazoles / Q000494:pharmacology / Q000627:therapeutic use; D002417:Cattle; D002418:Cattle Diseases / Q000175:diagnosis / Q000453:epidemiology*; D003429:Cross Reactions; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary*; D005210:Fasciola hepatica / Q000276:immunology*; D005211:Fascioliasis / Q000175:diagnosis / Q000453:epidemiology / Q000662:veterinary*; D005243:Feces / Q000469:parasitology; D008800:Mexico / Q000453:epidemiology; D010270:Parasite Egg Count; D012680:Sensitivity and Specificity; D016036:Seroepidemiologic Studies; D000077682:Triclabendazole; D014329:Tropical Climate
D000871:Anthelmintics; D000909:Antibodies, Helminth; D000947:Antigens, Helminth; D001562:Benzimidazoles; D000077682:Triclabendazole